CompoAtlas

ACTIBIOTA CHOLESTEROL

Food supplement declared in France, declaration No 2018-4-460

ACTIBIOTA CHOLESTEROL is a food supplement declared in France. Status: retiré du marché le 5 August 2026. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
COOPERATION PHARMACEUTIQUE FRANCAISE
Status
Retiré du marché le 5 August 2026
Form
Sachet
Daily dose
1 sachet
Directions for use
Le contenu du sachet est à dissoudre dans un demi verre d'eau
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Maladie rénale
Objectives stated by the manufacturer (these are not authorised claims)
Artères et cholestérol

Declaration 154352, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Monascus purpureus WentGrainePoudre (de plantes séchées ou broyées)350.88 mg

Other active ingredients

NamePer day
Ubiquinonenot declared

Micro-organisms

StrainPer day
Bifidobacterium Longum BB5361,000,000,000 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
NicotinamideNicotinamide (vitamine B3)900 mg54 mg

Additives

E420, E551, E955, E330, E412

Other ingredients

maltodextrine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas utiliser en cas de prise de médicaments hypolipidémiants. Déconseillé aux enfants, aux adolescents, aux femmes enceintes ou allaitantes, aux personnes sensibles aux statines, aux personnes souffrant de maladies rénales ou hépatiques et aux personnes ayant un taux anormalement élevé de transaminases.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line